Press "Enter" to skip to content

Novartis mulling $1.5 million-$5 million price range for SMA gene therapy

U.S. regulators are due to make a decision on approving Zolgensma next month.

Original source: https://health.economictimes.indiatimes.com/news/pharma/novartis-mulling-1-5-million-5-million-price-range-for-sma-gene-therapy/69028361?utm_source=RSS&utm_medium=ETRSS

Also Read:   California pharmacies rarely take back unused opioids